Indiana’s healthcare and life sciences sector, often hailed as a key driver of the state’s economy, landed a record $619.8 million in venture funding last year, a hefty increase over the previous record, set a year earlier.... Read More
Federal regulators have rejected Eli Lilly and Co.’s application for accelerated approval of an experimental treatment for Alzheimer’s disease due to a limited number of patients that were still on the drug for a full year in clinical trials.... Read More
It has no employees, no higher-education accreditation and only about $40,000 in the bank. But a group of physicians and business leaders, many with ties to DePauw University in Greencastle, is quietly drawing up plans to establish a medical school in Indiana with a focus on global health.... Read More
An Indianapolis company that repackages and distributes pharmaceuticals is planning a $10.5 million expansion that will include hiring another 205 people. Northwind Pharmaceuticals LLC plans to make the hires by the end of 2025.... Read More
Upset with what they say is the excessive cost of healthcare in Indiana, House Republicans want to levy fines against hospitals that charge more than 260% of what Medicare reimburses for services. House Bill 1004 would impose fines for excessive prices.... Read More
Indiana University Health said Monday the cost of its new downtown hospital complex will now top $4 billion, an increase of 60% over previous estimates, due to higher construction costs and a major increase in the number of patient rooms.... Read More
Dr. James Callaghan, CEO of Franciscan Health’s central Indiana hospitals since 2015, has been promoted to the health system’s corporate parent. Callaghan has been named senior vice president and chief operating officer for Mishawaka-based Franciscan Alliance.... Read More
A so-called “blank check company” launched last year by Indianapolis-based Emmis Corp. is liquidating without making any purchases. Monument Circle Acquisition Corp. says it will wind up operations before the end of the year ... Read More
Corteva Inc., the Indianapolis-based seed and insecticide giant, is buying Stoller Group, a Houston company that makes plant hormones, nutrients and microorganisms, for $1.2 billion. The two companies say they have signed a definitive agreement for the deal.... Read More
Corteva Inc., the Indianapolis-based seed and insecticide giant, is cutting roughly 1,000 workers as it reduces its portfolio of products and streamlines operations. A spokesperson declined to say how many jobs would be impacted in Indy.... Read More
